Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
Arashiro T, Arima Y, Muraoka H, Sato A, Oba K, Uehara Y, Arioka H, Yanai H, Kuramochi J, Ihara G, Chubachi K, Yanagisawa N, Nagura Y, Kato Y, Ueda A, Numata A, Kato H, Ishii K, Ooki T, Oka H, Nishida Y, Stucky A, Smith C, Hibberd M, Ariyoshi K, Suzuki M. Arashiro T, et al. Clin Infect Dis. 2023 Feb 8;76(3):e108-e115. doi: 10.1093/cid/ciac635. Clin Infect Dis. 2023. PMID: 35918782 Free PMC article.
Behavioral factors associated with SARS-CoV-2 infection in Japan.
Arashiro T, Arima Y, Muraoka H, Sato A, Oba K, Uehara Y, Arioka H, Yanai H, Yanagisawa N, Nagura Y, Kato Y, Kato H, Ueda A, Ishii K, Ooki T, Oka H, Nishida Y, Stucky A, Miyahara R, Smith C, Hibberd M, Ariyoshi K, Suzuki M. Arashiro T, et al. Influenza Other Respir Viruses. 2022 Sep;16(5):952-961. doi: 10.1111/irv.12992. Epub 2022 Apr 26. Influenza Other Respir Viruses. 2022. PMID: 35470969 Free PMC article.
Impact of the Coming-of-Age Day and ceremony on the risk of SARS-CoV-2 transmission in Japan: A natural-experimental study based on national surveillance data.
Ko YK, Kinoshita R, Yamauchi M, Otani K, Kamigaki T, Kasuya K, Yoneoka D, Arima Y, Kobayashi Y, Arashiro T, Otsuka M, Shimbashi R, Suzuki M. Ko YK, et al. Among authors: arashiro t. Influenza Other Respir Viruses. 2022 Nov;16(6):1026-1032. doi: 10.1111/irv.13027. Epub 2022 Jul 27. Influenza Other Respir Viruses. 2022. PMID: 35894771 Free PMC article.
Replacement of SARS-CoV-2 strains with variants carrying N501Y and L452R mutations in Japan: an epidemiological surveillance assessment.
Kobayashi Y, Arashiro T, Otsuka M, Tsuchihashi Y, Takahashi T, Arima Y, Ko YK, Otani K, Yamauchi M, Kamigaki T, Morita-Ishihara T, Takahashi H, Uchikoba S, Shimatani M, Takeshita N, Suzuki M, Ohnishi M. Kobayashi Y, et al. Among authors: arashiro t. Western Pac Surveill Response J. 2022 Sep 16;13(3):1-10. doi: 10.5365/wpsar.2022.13.3.943. eCollection 2022 Jul-Sep. Western Pac Surveill Response J. 2022. PMID: 36688179 Free PMC article.
Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies.
Arashiro T, Arima Y, Kuramochi J, Muraoka H, Sato A, Chubachi K, Oba K, Yanai A, Arioka H, Uehara Y, Ihara G, Kato Y, Yanagisawa N, Nagura Y, Yanai H, Ueda A, Numata A, Kato H, Oka H, Nishida Y, Ooki T, Nidaira Y, Stucky A, Suzuki T, Smith C, Hibberd M, Ariyoshi K, Suzuki M. Arashiro T, et al. Euro Surveill. 2023 Jan;28(4):2300034. doi: 10.2807/1560-7917.ES.2023.28.4.2300034. Euro Surveill. 2023. PMID: 36700869 Free PMC article. No abstract available.
National seroepidemiological study of COVID-19 after the initial rollout of vaccines: Before and at the peak of the Omicron-dominant period in Japan.
Arashiro T, Arai S, Kinoshita R, Otani K, Miyamoto S, Yoneoka D, Kamigaki T, Takahashi H, Hibino H, Okuyama M, Hayashi A, Kikuchi F, Morino S, Takanashi S, Wakita T, Tanaka-Taya K, Suzuki T, Suzuki M. Arashiro T, et al. Influenza Other Respir Viruses. 2023 Feb 1;17(2):e13094. doi: 10.1111/irv.13094. eCollection 2023 Feb. Influenza Other Respir Viruses. 2023. PMID: 36824391 Free PMC article.
Epidemiologic Trends and Distributions of Imported Infectious Diseases Among Travelers to Japan Before and During the COVID-19 Pandemic, 2016 to 2021: A Descriptive Study.
Kasamatsu A, Kanou K, Fukusumi M, Arima Y, Omori S, Nakamura H, Sato T, Serizawa Y, Takeda A, Fujikura H, Ikenoue C, Nishiki S, Fujiya Y, Arashiro T, Takahashi T, Shimada T, Suzuki M, Sunagawa T. Kasamatsu A, et al. Among authors: arashiro t. J Epidemiol. 2024 Apr 5;34(4):187-194. doi: 10.2188/jea.JE20230025. Epub 2023 Sep 30. J Epidemiol. 2024. PMID: 37331795 Free PMC article.
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan.
Arashiro T, Arima Y, Kuramochi J, Muraoka H, Sato A, Chubachi K, Yanai A, Arioka H, Uehara Y, Ihara G, Kato Y, Yanagisawa N, Ueda A, Kato H, Oka H, Nishida Y, Nidaira Y, Asami T, Jinta T, Nakamura A, Oba K, Taniyama D, Yamamoto K, Tanaka K, Ueshima K, Fuwa T, Stucky A, Suzuki T, Smith C, Hibberd M, Ariyoshi K, Suzuki M. Arashiro T, et al. Open Forum Infect Dis. 2023 May 3;10(6):ofad240. doi: 10.1093/ofid/ofad240. eCollection 2023 Jun. Open Forum Infect Dis. 2023. PMID: 37351451 Free PMC article.
46 results